ARTICLE | Clinical News
Mirvaso brimonidine tartrate regulatory update
January 6, 2014 8:00 AM UTC
On Dec. 19, 2013, EMA's CHMP issued a positive opinion recommending approval of an MAA from Galderma for Mirvaso brimonidine tartrate for the symptomatic treatment of facial erythema of rosacea in adu...